BioMedNewsBreaks – Octane’s Upcoming Forum to Showcase Visionary Speakers, Latest Advances in Medical Technology Sector

Octane, an organization leading the Southern California technology and medical technology business ecosystem, today announced that the 2022 Medical Innovation Forum will be held on Oct. 27-28 at the Irvine Marriott in Irvine, California. The two-day event will feature the most visionary speakers from the medical technology sector, showcase the latest advances, and offer access to unparalleled educational opportunities and the potential to network, explore synergies and foster long-term partnerships with fellow professionals. Investors looking for untapped opportunities will benefit from one-on-one, private meetings organized with fully vetted, early stage companies that are at the cutting edge of innovation in the medical field in Southern California.

“Southern California is one of the country’s most dynamic and promising markets, and Octane aims to create more than 55,000 technology jobs by 2030 here,” said Octane CEO Bill Carpou. “The Medical Innovation Forum is a key component of this larger vision and especially pertinent given the pandemic, rising health costs and aging demographics in many parts of the world. This event puts Southern California on the map and showcases how much innovation is taking place in the region. We hope to play our part in paving the way for more technological development, higher investments and fostering deeper regional networks.”

To view the full press release, visit https://ibn.fm/UaSAp

About Octane

Octane is building the SoCal of tomorrow by connecting people, resources and capital to fuel technology growth in Southern California. Its members represent technology executive leaders, entrepreneurs, investors, venture capitalists, academicians and strategic advisors, all working together to fuel innovation in the OC. The organization has helped more than 800 companies via the LaunchPad SBDC accelerator. LaunchPad companies have received more than $2.1 billion in investment and equity exits. Octane annually welcomes more than 7,000 people to its programs and events. More than 2,000 business leaders throughout the region are Octane members. For more information, visit www.Octaneoc.org.

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork